[1] 邢笑萌,赵茜,史晓宁,等.有自杀企图史的抑郁症住院患者临床特征研究[J].神经疾病与精神卫生,2020,20(3):163-167.
[2] SHAH A, BHAT R, ZARATE-ESCUDERO S, et al. Suicide rates in five-year age-bands after the age of 60 years: the international landscape[J]. Aging Ment Health, 2016, 20(2): 131-138.
[3] BROOKS S E, BURRUSS S K, MUKHERJEE K. Suicide in the elderly: a multidisciplinary approach to prevention[J]. Clin Geriatr Med, 2019, 35(1): 133-145.
[4] MARGARIT C, BALLESTER P, INDA M D, et al. OPRM1 gene interaction with sleep in chronic pain patients treated with opioids[J]. Pain Physician, 2019, 22(1):97-107.
[5] BERLOW Y A, ZANDVAKILI A, PHILIP N S. The clinical utility of imaging-defined biotypes of depression and transcranial magnetic stimulation: a decision curve analysis[J]. Brain Stimul, 2020, 13(4): 1069-1070.
[6] 俞丽华, 龚发金, 张咏梅. CYP2D6, OPRM1 基因多态性与老年抑郁症易感性的相关性[J]. 中国老年学杂志, 2022, 42(7):1699-1730.
[7] 马心慧, 孙海昕, 杜金赞, 等. 中国北方抑郁症与 OPRM1 基因多态性的相关性研究[J]. 武警医学, 2019, 30(2): 116-119.
[8] 陈静, 陆峥, 江三多, 等. 细胞色素 P4502D6 C188T 基因多态性与难治性抑郁症的关联[J]. 临床精神医学杂志, 2011, 21(4): 226-229.
[9] CONSOLONI J L, IBRAHIM E C, LEFEBVRE M N, et al. Serotonin transporter gene expression predicts the worsening of suicidal ideation and suicide attempts along a long-term follow-up of a Major Depressive Episode[J]. Eur Neuropsychopharmacol, 2018, 28(3):401-414.
[10] VANG F J, RYDING E, TRÄSKMAN-BENDZ L, et al. Size of basal ganglia in suicide attempters, and its association with temperament and serotonin transporter density[J]. Psychiatry Res, 2010, 183(2): 177-179.
[11] SUBLETTE M E, MILAK M S, GALFALVY H C, et al. Regional brain glucose uptake distinguishes suicide attempters from non-attempters in major depression[J]. Arch Suicide Res, 2013, 17(4): 434-447.
[12] VAI B, SERRETTI A, POLETTI S, et al. Cortico-limbic functional connectivity mediates the effect of early life stress on suicidality in bipolar depressed 5-HTTLPR* s carriers[J]. J Affect Disord, 2020, 263: 420-427.
[13] KENNA G A, RODER-HANNA N, LEGGIO L, et al. Association of the 5-HTT gene-linked promoter region (5-HTTLPR) polymorphism with psychiatric disorders: review of psychopathology and pharmacotherapy[J]. Pharmgenomics Pers Med, 2012: 19-35.
[14] COSTAFREDA S G, MCCANN P, SAKER P, et al. Modulation of amygdala response and connectivity in depression by serotonin transporter polymorphism and diagnosis[J]. J Affect Disord, 2013, 150(1):96-103.
[15] TOMBÁCZ D, MARÓTI Z, KALMÁR T, et al. High-coverage whole-exome sequencing identifies candidate genes for suicide in victims with major depressive disorder[J]. Sci Rep, 2017, 7(1):7106.
[16] KIM Y J, PARK H J, JAHNG G H, et al. A pilot study of differential brain activation to suicidal means and DNA methylation of CACNA1C gene in suicidal attempt patients[J]. Psychiatry Res, 2017, 255: 42-48.
[17] 宋子衿, 赖顺凯, 钟舒明, 等. 自杀行为的影像遗传学研究进展[J]. 中国医学科学院学报, 2021, 43(5): 801-807.
[18] GONDA X, SARGINSON J, ESZLARI N, et al. A new stress sensor and risk factor for suicide: the T allele of the functional genetic variant in the GABRA6 gene[J]. Sci Rep, 2017, 7(1): 12887.
[19] LEWIS C P, NAKONEZNY P A, BLACKER C J, et al. Cortical inhibitory markers of lifetime suicidal behavior in depressed adolescents[J]. Neuropsychopharmacology, 2018,43(9):1822-1831.
[20] KAMINSKY Z, WILCOX H C, EATON W W, et al. Epigenetic and genetic variation at SKA2 predict suicidal behavior and post-traumatic stress disorder[J]. Transl Psychiatry, 2015, 5(8): e627.
[21] YIN H, GALFALVY H, PANTAZATOS S P, et al. Glucocorticoid receptor-related genes: genotype and brain gene expression relationships to suicide and major depressive disorder[J]. Depress Anxiety, 2016, 33(6): 531-540.
[22] PANDEY G N, RIZAVI H S, ZHANG H, et al. The expression of the suicide-associated gene SKA2 is decreased in the prefrontal cortex of suicide victims but not of nonsuicidal patients[J]. Int J Neuropsychopharmacol, 2016, 19(8): pyw015.
[23] HWANG J P, YANG C H, HONG C J, et al. Association of APOE genetic polymorphism with cognitive function and suicide history in geriatric depression[J]. Dement Geriatr Cogn Disord, 2006, 22(4): 334-338. |
